Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer

被引：0
|
作者：
Fabrice Barlesi
Laure Deyme
Diane-Charlotte Imbs
Elissa Cousin
Mathieu Barbolosi
Sylvanie Bonnet
Pascale Tomasini
Laurent Greillier
Melissa Galloux
Albane Testot-Ferry
Annick Pelletier
Nicolas André
Joseph Ciccolini
Dominique Barbolosi
机构：
[1] Aix Marseille University,Marseille Early Phases Cancer Trials Center CLIP
[2] APHM,SMARTc Unit Centre de Recherche en Cancérologie de Marseille Inserm U1068
[3] Aix Marseille University,Department of Pharmacology Marseille
[4] Gustave Roussy Cancer Campus,undefined
[5] Aix Marseille University,undefined
[6] APHM,undefined
[7] Metronomics Global Health Initiative,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2022年 / 90卷
关键词：
Lung cancer; Mesothelioma; Mathematical modelling; Vinorelbine; Metronomic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：149 / 160
页数：11
相关论文
共 50 条
  • [1] Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer
    Barlesi, Fabrice
    Deyme, Laure
    Imbs, Diane-Charlotte
    Cousin, Elissa
    Barbolosi, Mathieu
    Bonnet, Sylvanie
    Tomasini, Pascale
    Greillier, Laurent
    Galloux, Melissa
    Testot-Ferry, Albane
    Pelletier, Annick
    Andre, Nicolas
    Ciccolini, Joseph
    Barbolosi, Dominique
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (02) : 149 - 160
  • [2] Phase I trial of metronomic oral vinorelbine in patients with advanced cancer
    Lakshmi Rajdev
    Abdissa Negassa
    Qun Dai
    Gary Goldberg
    Kathy Miller
    Joseph A. Sparano
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1119 - 1124
  • [3] Phase I trial of metronomic oral vinorelbine in patients with advanced cancer
    Rajdev, Lakshmi
    Negassa, Abdissa
    Dai, Qun
    Goldberg, Gary
    Miller, Kathy
    Sparano, Joseph A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) : 1119 - 1124
  • [4] Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial
    Guetz, Sylvia
    Tufman, Amanda
    von Pawel, Joachim
    Rittmeyer, Achim
    Borgmeier, Astrid
    Ferre, Pierre
    Edlich, Birgit
    Huber, Rudolf Maria
    ONCOTARGETS AND THERAPY, 2017, 10 : 1081 - 1089
  • [5] A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Saridaki, Zacharenia
    Malamos, Nikolaos
    Kourakos, Panagiotis
    Polyzos, Aristides
    Ardavanis, Alexandros
    Androulakis, Nikolaos
    Kalbakis, Kostas
    Vamvakas, Lambros
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 35 - 42
  • [6] A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Zacharenia Saridaki
    Nikolaos Malamos
    Panagiotis Kourakos
    Aristides Polyzos
    Alexandros Ardavanis
    Nikolaos Androulakis
    Kostas Kalbakis
    Lambros Vamvakas
    Vassilis Georgoulias
    Dimitris Mavroudis
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 35 - 42
  • [7] Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients
    Barlesi, Fabrice
    Imbs, Diane-Charlotte
    Tomasini, Pascale
    Greillier, Laurent
    Galloux, Melissa
    Testot-Ferry, Albane
    Garcia, Melanie
    Elharrar, Xavier
    Pelletier, Annick
    Andre, Nicolas
    Mascaux, Celine
    Lacarelle, Bruno
    El Cheikh, Raouf
    Serre, Raphael
    Ciccolini, Joseph
    Barbolosi, Dominique
    ONCOTARGET, 2017, 8 (29) : 47161 - 47166
  • [8] A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC
    Athanasios G. Pallis
    Vassilis Chandrinos
    Georgia Pavlakou
    Nikolaos Xenidis
    Ioannis Varthalitis
    Nikolaos Vardakis
    Lambros Vamvakas
    Emmanouel Kontopodis
    Maria Rovithi
    Vassilis Georgoulias
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1239 - 1245
  • [9] A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC
    Pallis, Athanasios G.
    Chandrinos, Vassilis
    Pavlakou, Georgia
    Xenidis, Nikolaos
    Varthalitis, Ioannis
    Vardakis, Nikolaos
    Vamvakas, Lambros
    Kontopodis, Emmanouel
    Rovithi, Maria
    Georgoulias, Vassilis
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1239 - 1245
  • [10] Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
    Roy S. Herbst
    Cathleen Lynch
    Michael Vasconcelles
    Beverly A. Teicher
    Gary Strauss
    Anthony Elias
    Ian Anderson
    Patrick Zacarola
    Nam H. Dang
    Traci Leong
    Ravi Salgia
    Arthur T. Skarin
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 151 - 159
12345